Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV

Clinical trial NCT06413121 · COMPLETED

Trial details

NCT number: NCT06413121
Sponsor: Serum Institute of India Pvt. Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diptheria Immunization Tetanus Immunization Pertussis Immunization Hepatitis B Immunization Haemophilus Influenzae Type B Immunization Polio Immunization

Start date: 2024-05-09
Primary completion: 2025-03-04
Enrollment: 1557

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.